Carlito B. Lebrilla

Matrubials is developing novel antibacterial therapeutics to address non-selectivity and emerging antimicrobial resistance. They provide safe solutions that can reduce the healthcare and economic burden resulting from bacterial infections and concomitant clinical complications. That develops the anti-pathogenic molecules from milk into therapeuticsgeared towards all-age diseases.